Clinical Trials Directory

Trials / Completed

CompletedNCT02816411

Protein Supplementation and Skeletal Muscle Healing Process

Effects of Protein Supplementation on Skeletal Muscle Regeneration and Healing Process Following Exercise-induced Aseptic Injury

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
University of Thessaly · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

In this study the investigators utilized protein supplementation over an 8-day period following eccentric exercise-induced muscle damage in order to test the initial hypotheses : i) protein supplementation after exercise-induced muscle injury affects exercise-induced aseptic inflammation and muscle performance.

Detailed description

The objective was to examine weather protein supplementation is able to affect the inflammatory response as well as recovery of muscle performance following an intense eccentric exercise protocol. In a double-blind, counterbalanced design, 14 men received either Placebo (PLA) or milk protein isolate (PRO) for 8 consecutive days following a single bout of exercise (300 eccentric contractions at 30 deg/sec). In both conditions, performance was assessed at baseline, immediately post-exercise, 2h post-exercise and daily for 8 consecutive days. Blood samples were collected at baseline, 2h post-exercise and daily for the remaining 8 days. Muscle biopsies from vastus lateralis were collected at baseline as well as at day 2 and day 8 of the post-exercise period.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMilk protein isolateMilk protein isolate in a powder form consisted of 80% casein and 20% whey protein. 20g were diluted into 500 ml water. Placebo consisted of 365 ml water, 125 ml sugar-free cordial and 2g of low-calorie glucose/dextrose powder.
DIETARY_SUPPLEMENTPlacebo500 mL drink that contained water (375 mL), sugar-free cordial (125 mL) and 2 g of low-calorie glucose/dextrose powder.

Timeline

Start date
2014-05-01
Primary completion
2016-02-01
Completion
2016-07-01
First posted
2016-06-28
Last updated
2016-10-04

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT02816411. Inclusion in this directory is not an endorsement.